Scope of this ESSENTIAL
|
This ESSENTIAL describes the regulatory requirements of In-Vitro Diagnostics medical devices in the European Union, based on the - Regulation (EU) 2017/746 and its amendments - MDCG (EU Medical Device Coordination Group) documents
Definition of "‘In-Vitro Diagnostic medical device" acc. to Article 2 of Regulation (EU) 2017/746: "In-Vitro Diagnostic medical device" means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, piece of equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information on one or more of the following: a) concerning a physiological or pathological process or state; b) concerning congenital physical or mental impairments; c) concerning the predisposition to a medical condition or a disease; d) to determine the safety and compatibility with potential recipients; e) to predict treatment response or reactions; f) to define or monitoring therapeutic measures
IVD products are classified into four risk classes, according to the risk associated with their use. ANNEX VIII - CLASSIFICATION RULES, Chapter 2, Rule 1 - 7. Class A Class B Class C Class D
Not in scope of this CRF: - Medical Devices (see: ESSENTIAL EEA Medical Devices)'
|